XML 21 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash Flows From Operating Activities:      
Net (loss)/earnings $ (8,933) $ 8,040 $ 6,345
Adjustments to reconcile net (loss)/earnings to net cash provided by operating activities:      
Depreciation and amortization, net 9,600 9,760 10,276
Deferred income taxes (2,089) (3,288) (2,738)
Stock-based compensation 507 518 457
Impairment charges 2,963 255 179
Divestiture gains and royalties (1,119) (884) (1,063)
Acquired IPRD 13,373 913 815
Equity investment (gains)/losses, net (16) 160 801
Other adjustments 94 300 223
Changes in operating assets and liabilities:      
Receivables 264 (995) (663)
Inventories (486) (751) (69)
Accounts payable 184 198 109
Rebates and discounts 1,484 904 427
Income taxes payable (1,260) (603) (1,423)
Other 624 (667) (610)
Net cash provided by operating activities 15,190 13,860 13,066
Cash Flows From Investing Activities:      
Sale and maturities of marketable debt securities 1,122 733 6,411
Purchase of marketable debt securities (769) (1,774) (3,592)
Proceeds from sales of equity investments 265 215 218
Capital expenditures (1,248) (1,209) (1,118)
Divestiture and other proceeds 1,099 909 1,305
Acquisition and other payments, net of cash acquired (21,821) (1,169) (4,286)
Net cash used in investing activities (21,352) (2,295) (1,062)
Cash Flows From Financing Activities:      
Proceeds from issuance of short-term debt obligations 2,987 0 0
Repayments of short-term debt obligations (3,000) 0 0
Other short-term financing obligations, net 99 (120) 194
Proceeds from issuance of long-term debt 12,883 4,455 5,926
Repayments of long-term debt (2,873) (3,879) (11,431)
Repurchase of common stock 0 (5,155) (8,001)
Dividends (4,863) (4,744) (4,634)
Stock option proceeds and other, net (106) 27 984
Net cash provided by/(used in) financing activities 5,127 (9,416) (16,962)
Effect of exchange rates on cash, cash equivalents and restricted cash (137) 45 (33)
(Decrease)/increase in cash, cash equivalents and restricted cash (1,172) 2,194 (4,991)
Cash, cash equivalents and restricted cash at beginning of period 11,519 9,325 14,316
Cash, cash equivalents and restricted cash at end of period $ 10,347 $ 11,519 $ 9,325